BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 30310069)

  • 1. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
    Collet R; Caballero-Ávila M; Querol L
    Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of immune-mediated inflammatory neuropathies.
    Hadden RD; Hughes RA
    Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, epidemiology and treatment of inflammatory neuropathies.
    Baig F; Knopp M; Rajabally YA
    Br J Hosp Med (Lond); 2012 Jul; 73(7):380-5. PubMed ID: 22875431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Lindenbaum Y; Kissel JT; Mendell JR
    Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute and chronic inflammatory neuropathies--therapy].
    Köller H; Kieseier BC; Jander S; Hartung HP
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1405-7. PubMed ID: 12813675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.